Emerging data suggest Retatrutide , a dual stimulator targeting both incretin and glucose-dependent insulinotropic polypeptide , may provide a significant development for obesity management . Early human investigations have shown considerable decreases in abdominal fat , potentially exceeding existing weight-loss treatments. Nevertheless , more eva